Skip to main content
Drug bottle and Pill

Compare Enbrel vs. Cosentyx

Head-to-head comparisons of medication uses, side effects, warnings, and more.

Key takeaways

Enbrel (etanercept) and Cosentyx (secukinumab) are both injectable medications used to treat autoimmune conditions, but they have some key differences. Enbrel is a biologic DMARD that works by blocking a protein called tumor necrosis factor (TNF) to reduce inflammation, while Cosentyx is an interleukin (IL)-17 inhibitor that targets a different protein in the immune system. Enbrel is typically injected weekly, whereas Cosentyx is usually injected monthly after an initial loading period. Cosentyx is only available as a brand-name product, making it potentially more expensive, while Enbrel is also available in a less costly biosimilar form. Enbrel and Cosentyx can both be used in children as young as 2 years old for certain conditions. Both medications can increase the risk of infections, but Cosentyx may also worsen inflammatory bowel disease symptoms. Additionally, Enbrel has been associated with a higher risk of certain cancers and nervous system effects, which are not commonly reported with Cosentyx.

Browse medications

View All

Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.